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Abstract
Group A Streptococcus (GAS) is a common and versatile hu-
man pathogen causing a variety of diseases. One of the 
many virulence factors of GAS is the secreted pore-forming 
cytotoxin streptolysin O (SLO), which has been ascribed mul-
tiple properties, including inflammasome activation leading 
to release of the potent inflammatory cytokine IL-1β from 
infected macrophages. IL-1β is synthesized as an inactive 
pro-form, which is activated intracellularly through proteo-
lytic cleavage. Here, we use a macrophage infection model 
to show that SLO specifically induces ubiquitination and 
degradation of pro-IL-1β. Ubiquitination was dependent on 
SLO being released from the infecting bacterium, and pore 
formation by SLO was required but not sufficient for the in-
duction of ubiquitination. Our data provide evidence for a 
novel SLO-mediated mechanism of immune regulation, em-
phasizing the importance of this pore-forming toxin in bac-
terial virulence and pathogenesis. © 2019 The Author(s) 
Published by S. Karger AG, Basel
Introduction
A common trait among pathogenic microbes is their 
ability to circumvent or counteract the protective mea-
sures induced by an invaded host, often taking advantage 
of host factors or processes for their own benefit. One 
network within host cells frequently exploited or manip-
ulated by pathogens is the ubiquitination system [1]. In 
this study, we demonstrate that the common human 
pathogen Group A Streptococcus (GAS or Streptococcus 
pyogenes) induces ubiquitination and degradation of the 
inactive pro-form of the inflammatory cytokine IL-1β, an 
event that is dependent on the bacterial virulence factor 
streptolysin O (SLO).
Ubiquitin is a small and a highly conserved protein 
that can be covalently attached to a substrate protein and 
thereby modify its activity, function or localization, or 
mark it for secretion or destruction [2]. Ubiquitination 
occurs in a 3-step enzymatic process and results in either 
the attachment of a single ubiquitin, or ubiquitin chains 
that may be linear or branched. Within such chains, ubiq-
uitin proteins can be linked together via any of its 7 lysines 
(K6, K11, K27, K29, K33, K48, or K63) or via the N-ter-
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minal methionine (M1). The nature of the ubiquitin link-
age dictates the fate of the substrate protein; K48-linked 
poly-ubiquitin chains generally target proteins for pro-
teasomal degradation, whereas M1- (linear) or K63-
linked chains are mostly associated with, for example, 
protein-protein interactions, protein trafficking, or deg-
radation of proteins by autophagy [2, 3].
The Nlrp3 inflammasome is an intracellular protein 
complex that is assembled and activated in response to 
a wide range of stimuli, mostly pertaining to disruptions 
in cellular homeostasis [4]. Within an inflammasome, 
the cysteine protease caspase-1 may cleave the inactive 
proforms of the inflammatory cytokines IL-1β and IL-18 
into their active forms, and also initiate a pro-inflamma-
tory type of cell death known as pyroptosis through pro-
cessing of the pore-forming protein gasdermin D [5]. 
The inflammasome plays an important role in innate 
immunity and is a key mediator of powerful inflamma-
tory signals upon infection as well as sterile tissue dam-
age. The activity and function of these complexes are 
tightly regulated, both at the level of generation and 
through post-translational modification of the pro-IL-
1β protein per se. Several of these control measures are 
mediated by ubiquitination and deubiquitination pro-
cesses [6–11].
GAS is an extracellular bacterial pathogen responsible 
for superficial as well as severe and sometimes life-threat-
ening diseases, causing around 500,000 deaths annually 
[12]. This bacterium produces an impressive set of viru-
lence factors, among them a variety of secreted toxins, 
proteases and superantigens with prominent roles in 
pathogenesis. The 2 pore-forming proteins SLO and 
streptolysin S act through different mechanisms but are 
both membrane-damaging toxins with the ability to lyse 
red blood cells [13]. Of particular interest for this study is 
SLO, which belongs to a family of cholesterol-dependent 
cytolysins that can insert into the lipid bilayer of host cell 
membranes and may result in pores up to 50 nm in diam-
eter [14]. SLO has been ascribed multiple functions in-
cluding the induction of oncosis or apoptosis in macro-
phages [15, 16], and prevention of phagolysosomal acidi-
fication and xenophagic killing in keratinocytes [17, 18]. 
In addition, SLO is a known activator of the inflamma-
some and generates release of mature IL-1β from macro-
phages [19, 20]. The role of IL-1β in GAS infection seems 
complex both in human disease and in murine experi-
mental settings, and presumably appropriate manage-
ment of the levels of this very potent proinflammatory 
cytokine is important to the pathogen as well as the in-
fected host [21–25].
Here, we describe a previously unknown capacity of 
GAS to induce SLO-dependent ubiquitination of pro-IL-
1β. This ubiquitination event results in increased pro-IL-
1β degradation, thus limiting the amount of pro-IL-1β 
available for inflammasome-mediated maturation and 
reducing the release of pro-inflammatory IL-1β.
Materials and Methods
Bacterial Strains and Growth Conditions
The wild type (wt) GAS strain 854 is an M type 1 strain isolated 
from a patient with a retroperitoneal abscess [26]. The isogenic 
mutant strains used in this study are listed in Table 1. Bacteria were 
grown in Todd-Hewitt broth supplemented with 0.5% yeast ex-
tract (THY) in 5% CO2 at 37  ° C. Overnight cultures were reinocu-
lated in THY and grown to late exponential phase (optical density 
of 1.1–1.3 at 600 nm), washed with phosphate-buffered saline, and 
diluted before use.
Mice
Genetically modified mouse strains IL-1β–/– [27], cas-
pase-1/11–/– [28], Asc–/– [29], Nlrp3–/– [30] and receptor-interact-
ing kinase 3 (Rip3)–/– [31] were all on a C57BL/6 (B6) background. 
B6 mice were bred in-house. Genetically modified mice or cells 
from such mice were kindly provided by Catharina Svanborg (IL-
1β–/–), Bengt Johansson-Lindbom (caspase-1/11–/–) and Russell E. 
Vance (Asc–/–, Nlrp3–/–). Rip3–/– mice were originally generated by 
K. Newton and V. Dixit (Genentech), and provided to E. Lien by 
Drs. Kaiser, Mocarski, Dillon and Green. All animal experiments 
were conducted in accordance with protocols approved by the 
Lund/Malmö Animal Ethics Committee.
Generation and Infection of Bone Marrow-Derived 
Macrophages
Bone marrow was isolated from murine femurs and tibiae, and 
progenitor cells were differentiated into bone marrow-derived 
macrophages (BMDMs) for 7 days (37  ° C, 5% CO2) in RPMI 1,640 
(Gibco) supplemented with 10% fetal bovine serum (Sigma), 2.5 
mM L-glutamine, and macrophage colony-stimulating factor. Pri-
or to infection, 10 × 106 BMDMs were seeded on 90 mm Petri 
dishes (unless otherwise stated), primed with 1 µg/mL lipopoly-
saccharide (LPS; Sigma) for 4 h, and infected at a multiplicity of 
infection of 20 and incubated for 90 min (unless otherwise stated). 
For longer incubation times, the bacterial suspension was re-
placed with fresh medium containing 300 µg/mL gentamicin (Sig-
Table 1. Description and references of streptococcal strains used in 
this study
Strain name Genotype and properties Ref.
wt Wild-type, GAS strain 854 [26]
∆slo slo deletion mutant [17]
slo(Y255A) SLO Y255A point mutation, lack pore 
formation ability
[17]
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ma) to kill extracellular bacteria at 90 min post infection. When 
indicated, BMDMs were stimulated with recombinant SLO 
(rSLO; Bio-Rad) at the concentration of 10 µg/mL in the presence 
or absence of ∆slo bacteria. Cell culture medium was supplement-
ed with 50 mM KCl (Sigma) in order to block K+ efflux. Nigericin 
(Sigma) was used at 10 µM concentration for 60 min. MG-132 
(Sigma), 3-Methyladenine (3-MA; Sigma) or Bafilomycin A1 
(Sigma) were added to the cell cultures 30 min before infection 
and were present throughout the whole infection at indicated 
concentrations.
Soluble IL-1β Measurement
Supernatants from infected BMDMs were cleared from debris 
by centrifugation (300 g, 5 min) and analyzed using IL-1β ELISA 
kits (BD Biosciences or R&D Systems) according to the manufac-
turer’s instructions. 
Immunoprecipitation and Deubiquitinase Treatment
Cells used for infection were lysed with NP-40 cell lysis buffer 
(150 mM sodium chloride, 1% NP-40 [Sigma], 50 mM Tris, com-
plete protease inhibitor cocktail [Roche]). Lysates were incubated 
with 0.3 µg antibody (IL-1β: AF-401 [R&D Systems], IL-18: 5180R 
[BioVision])/106 cells at 4  ° C overnight and precipitated using pro-
tein G Dynabeads (Thermo Scientific) incubated at 4  ° C for 1 h. 
When indicated, precipitated samples were digested with deubiq-
uitinase enzymes (DUB) using the UbiCREST DUB Set (Boston 
Biochem) according to the manufacturer’s instructions. Precipi-
tated proteins were eluted by incubation at 70  ° C for 10 min using 
elution buffer containing lithium dodecyl sulfate (Thermo Scien-
tific) under reducing conditions. 
Protein Separation and Immunoblot Assays
Following infection of 5 × 105 BMDMs as described above, cell 
lysates were prepared by using NP-40 lysis buffer followed by the 
addition of lithium dodecyl sulfate sample buffer and sample re-
ducing agent (Life Technologies). Whole cell lysates or precipi-
tated samples were separated by SDS-PAGE using NuPAGE 12% 
bis-Tris gels (Life Technologies) under reducing conditions and 
transferred to hybond polyvinylidene difluoride. For the analysis 
presented in Figure 5, whole cell lysates were run on a 4–15% 
TGX Stain Free Gel (Bio-Rad), and transferred to polyvinylidene 
difluoride membranes using the Trans-Blot Turbo Transfer Sys-
tem (Bio-Rad). This system allows UV-based detection of total 
protein content in each lane after transfer to the membrane. For 
detection, the following primary and horseradish peroxidase-
conjugated secondary antibodies were used: anti-IL-1β (AF-401; 
R&D Systems), anti-IL-18 (5180R; BioVision), anti-caspase-1 
p20 (AG-20B-0042; AdipoGen), anti-caspase-8 (ALX 804-448; 
Enzo), anti-Rip1 (clone D94C12; Cell Signaling), anti-Rip3 (2283; 
ProSci), anti-A20 (56309; Cell Signaling), anti-pan-ubiquitin 
(clone P4D4; Santa Cruz Biotechnology), anti-GAPDH (G9545; 
Sigma), rabbit anti-goat IgG (61-1620; Thermo Scientific or 705-
035-003; Jackson Immuno Research), donkey anti-mouse IgG 
(715-036-151; Jackson Immuno Research), donkey anti-rat IgG 
(712-036-153; Jackson), and goat anti-rabbit IgG (111-035-144; 
Jackson). Stained membranes were incubated in Clarity Western 
ECL blotting substrate for chemiluminescence (Bio-Rad) and de-
veloped. Blots were documented and quantified using ChemiDoc 
imaging system (Bio-Rad), Quantity One and Image Lab soft-
ware.
Statistical Analysis
Statistical calculations were performed using Prism version 7.0 
(GraphPad software). Data were analyzed using 1-way ANOVA (3 
or more groups with 1 categorical variable) or 2-way ANOVA (3 
or more groups with 2 categorical variables): ns, not significant, *** p < 0.001.
Results
GAS Expressing SLO Induces Ubiquitination of  
Pro-IL-1β in Macrophages
Nlrp3 inflammasome activation and maturation of 
IL-1β requires 2 sequential signals [32], the first one (re-
ferred to as “priming”) mediates the upregulation of the 
Nlrp3 and pro-IL-1β proteins in addition to multiple 
post-translational modifications of proteins involved in 
the inflammasome complex. Priming is commonly a re-
sponse to a microbial ligand or endogenous danger sig-
nal, and can be achieved through receptors activating the 
transcription factors NF-κB and AP-1 [32]. In vivo, 
priming is likely to occur through multiple receptors, in 
vitro however priming is often mediated by LPS through 
TLR4. The second signal (“activation”) leads to the as-
sembly of the inflammasome complex, caspase-1 activa-
tion and cleavage and secretion of mature IL-1β, and can 
be mediated by a wide array of stimuli, including SLO 
[19, 20]. As ubiquitination has previously been reported 
to influence levels of secreted IL-1β [7, 9, 10], we set out 
to investigate the potential role for ubiquitination in the 
regulation of mature IL-1β release during GAS infection. 
We used immunoprecipitation to isolate pro-IL-1β from 
LPS-primed, GAS-infected murine BMDMs and re-
vealed possible ubiquitination of the precipitate by west-
ern blotting. In agreement with existing data [9, 10], LPS 
priming induced a low level of pro-IL-1β ubiquitination 
(Fig. 1a). This post-translational modification has previ-
ously been shown to support more efficient maturation 
and secretion of IL-1β [9]. Upon infection with wt GAS, 
pro-IL-1β ubiquitination was markedly increased, while 
this was not observed in cells infected with an isogenic 
bacterial mutant lacking SLO expression (Δslo; Fig. 1a). 
As expected, no ubiquitinated protein could be detected 
after IL-1β immunoprecipitation of primed IL-1β–/– 
BMDMs (Fig. 1a), confirming the specificity of the IL-1β 
antibody. Of note, this antibody recognizes pro- and ma-
ture IL-1β alike, implying that both forms may be pre-
cipitated in our assays. However, cleaved IL-1β is rap-
idly released from the cell and consequently mature IL-
1β is not readily detectable in lysates of cells where the 
inflammasome has been activated. Indeed, we did not 
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observe any cleaved IL-1β in the precipitated samples 
from cells infected with wt GAS (Fig. 1b), suggesting that 
the detected ubiquitination pattern mostly reveals post-
transcriptional modifications of the pro-form (Fig. 1a). 
This does not exclude the possibility that released mature 
IL-1β may also be ubiquitinated, although ubiquitin is 
commonly detached from target proteins before secre-
tion as part of the maintenance of ubiquitin homeostasis 
in the cell [33]. The ubiquitination of pro-IL-1β was vis-
ible after 60 min and increased up to 180 min of infection 
(Fig.  1c), demonstrating kinetics similar to that of in-
flammasome-dependent IL-1β release after GAS infec-
tion of macrophages (Fig. 1d). Nlrp3 inflammasome ac-
tivation may also lead to the maturation and secretion of 
IL-18 [34], the pro-form of this cytokine, however, does 
not seem to be ubiquitinated upon GAS infection of BM-
DMs (Fig. 1e).
Taken together, these data suggest that GAS infection 
of macrophages rapidly induces increased ubiquitination 
of pro-IL-1β, but not pro-IL-18, and that this process is 
dependent on the cytolysin SLO.
Pro-IL-1β Ubiquitination Induced by SLO Requires 
Pore Formation
SLO is secreted from the bacteria as monomers, which 
oligomerize into a prepore on the host cell membrane. 
The prepore complex then inserts fully into the mem-
brane to form a pore that can reach as much as 50 nm in 
0
5,000
10,000
15,000
IL-
1β
, p
g/
m
L
0 30 60 90 180
Time, min
ns
***
***
***
wt
a b
c d e
LPS
GAS
MØ
–
–
+
–
+
wt
+
Δs/o
+
–
    IL-1β–/–B6
Ub
Pro-IL-1β
IL-1β IP
191
97
64
51
28 LPSGAS
–
–
+
–
+
wt
Pro-IL-1β
Cleaved-IL-1β
IL-1β IP 28
39
19
LPS
GAS
Time, min
+
–
+ + + +
wt
30 60 90 180
Ub
Pro-IL-1β
IL-1β IP
LPS
GAS
+
–
+
wt
Pro-IL-18
Ub
IL-18 IP
Fig. 1. Group A Streptococcus (GAS) expressing streptolysin O 
(SLO) induces ubiquitination of pro-IL-1β in macrophages. a B6 
macrophages were primed with lipopolysaccharide (LPS) or 
primed and infected with GAS as indicated and cell lysates were 
subjected to IL-1β immunoprecipitation (IP) and immunoblot 
analysis for ubiquitin (Ub) and (pro-)IL-1β. Primed IL-1β–/– mac-
rophages were used as a control for specificity. b IL-1β IP and im-
munoblot analysis of lysates from LPS-primed or primed and in-
fected macrophages, as indicated. c Macrophages were primed 
with LPS or primed and infected with wild type (wt) GAS for the 
indicated times. IL-1β was precipitated from cell lysates and ana-
lyzed for Ub and (pro-)IL-1β by immunoblot. d LPS-primed mac-
rophages were infected by wt GAS and levels of released IL-1β were 
assessed by ELISA. e IL-18 was precipitated from cell lysates of 
LPS-primed or primed and infected macrophages, as indicated, 
followed by immunoblot analysis for Ub and (pro-)IL-18. Blots 
show 1 representative of 2 or 3 independent experiments. Graph 
shows means plus SD for triplicate samples and is representative 
of 2 independent experiments.
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diameter [14, 35]. Complete pore formation is required 
for the induction of cell lysis and inflammasome activa-
tion [35], which seems to be the case also for similar tox-
ins found in other bacterial pathogens, such as the Listeria 
monocytogenes listeriolysin O [36] and pneumolysin se-
creted by S. pneumoniae [37].
Through the introduction of point mutations into 
SLO, pore formation can be blocked at different steps of 
the oligomerization-insertion process [38]. To study the 
effect of the pore forming capacity of SLO on pro-IL-1β 
ubiquitination, we took advantage of an isogenic bacte-
rial strain expressing a mutated form of SLO that is locked 
in the prepore stage (slo[Y255A]), thus secreting SLO 
monomers that oligomerize on the host cell membrane 
but are not able to fully insert and form pores [17]. We 
observed decreased pro-IL-1β ubiquitination (Fig.  2a), 
and as expected also reduced IL-1β release (Fig. 2b), in 
BMDMs infected with the mutant strain compared to wt 
GAS, suggesting that pore-formation is important not 
only for inflammasome activation by SLO but also for 
SLO-mediated ubiquitination of pro-IL-1β.
Pore-formation by SLO induces multiple processes in 
the affected cell [13]. To investigate whether ubiquitina-
tion of pro-IL-1β was a response induced primarily by 
the membrane damage caused by SLO, or by the strepto-
coccal infection, we treated LPS-primed BMDMs with 
rSLO in the absence of bacteria. While rSLO efficiently 
induced the release of mature IL-1β (Fig. 2b), it was not 
able to promote ubiquitination of the IL-1β proform 
(Fig. 2a). Similarly, the addition of rSLO during an infec-
tion with the Δslo bacterial strain did not generate pro-
IL-1β ubiquitination (Fig. 2a) but as expected resulted in 
efficient IL-1β release (Fig. 2b). These observations allow 
us to conclude that SLO needs to be expressed and se-
creted from the bacterium during infection in order to 
support pro-IL-1β ubiquitination and that pore-forma-
tion by SLO is required, but not sufficient, for the ubiq-
uitination process. Further, in contrast to the baseline 
ubiquitination of pro-IL-1β that is induced by LPS prim-
ing [9], the additional ubiquitination of pro-IL-1β in-
duced by SLO-proficient streptococcal infection does 
not seem to be required to facilitate subsequent release of 
mature IL-1β.
Streptococcus-Induced Ubiquitination of  
Pro-IL-1β Occurs Independently of SLO-Mediated 
Inflammasome Signaling
Inflammasome activation and IL-1β release induced 
by GAS is known to be mostly due to pore-formation by 
SLO and to be dependent on the inflammasome sensor 
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Fig. 2. Pro-IL-1β ubiquitination is dependent on bacterial secre-
tion of and pore formation by streptolysin O (SLO). LPS-primed 
B6 macrophages were infected with wild type (wt), Δslo or 
slo(Y255A) Group A Streptococcus (GAS) or stimulated with 10 
µg/mL recombinant SLO (rSLO) for 90 min in the presence or ab-
sence of Δslo bacteria, as indicated. a IL-1β precipitates from cell 
lysates were assayed for ubiquitin (Ub) and (pro-)IL-1β by immu-
noblot. b Supernatants were analyzed for IL-1β by ELISA. Blot 
shows 1 representative of at least 3 independent experiments. 
Graph shows means plus SD for triplicate samples and is represen-
tative of 3 independent experiments.
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protein Nlrp3, the linker protein ASC and the cysteine 
protease caspase-1 [19, 20]. Because we found a require-
ment for SLO in pro-IL-1β ubiquitination, we hypothe-
sized that ubiquitination may occur as a response to SLO-
mediated inflammasome activation. Thus, we infected B6 
(wt) BMDMs or BMDMs deficient for the components 
required for inflammasome activation by GAS (Nlrp3, 
ASC and caspase-1, knock-outs on B6 background) and 
analyzed them for IL-1β release and pro-IL-1β ubiquiti-
nation. As expected, Nlrp3, ASC, and caspase-1 were all 
required for release of mature IL-1β upon GAS infection 
(Fig. 3a). However, pro-IL-1β was ubiquitinated also in 
their absence (Fig. 3b), suggesting that this ubiquitination 
event is not a process mediated by inflammasome activa-
tion per se. Although the amounts of pro-IL-1β were sim-
ilar in cell lysates of different genotype BMDMs, the ubiq-
uitination pattern appeared stronger in caspase-1-, and 
particularly ASC-deficient as compared to B6 macro-
phages (Fig.  3b), suggesting that these well-known in-
flammasome components may affect the regulation of the 
ubiquitination process.
The Nlrp3 inflammasome can be activated by a num-
ber of bacterial toxins [39], and although the actual mo-
lecular mechanisms governing its activation are still 
largely unknown, in most cases, it can be blocked by the 
inhibition of K+ efflux from the cell, suggesting the dis-
ruption of intracellular ion homeostasis may be an acti-
vating trigger [4]. To explore whether the ion flux con-
duits affecting inflammasome activation may be involved 
in pro-IL-1β ubiquitination, BMDMs supplemented with 
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Fig. 3. Streptococcus-induced ubiquitination of pro-IL-1β oc-
curs  independently of SLO-mediated inflammasome signaling. 
a Primed macrophages of different genotypes were infected with 
wild type (wt) or Δslo Group A Streptococcus (GAS), as indicated. 
The Nlrp3 inflammasome-activating toxin Nigericin (Nig) was 
used as a control. Supernatants were assessed for IL-1β by ELISA. 
b Different genotype macrophages were primed and infected with 
wt or Δslo GAS. IL-1β was precipitated from cell lysates and ubiq-
uitin (Ub) and (pro-)IL-1β were assessed by immunoblot. c B6 
macrophages were primed or primed and infected or treated with 
Nig, as indicated, in the presence or absence of KCl and IL-1β in 
the supernatant was assessed by ELISA. d B6 macrophages were 
primed or primed and infected, as indicated, in the presence or 
absence of KCl and IL-1β was precipitated from cell lysates and 
ubiquitin (Ub) and (pro-)IL-1β were assessed by immunoblot. 
Graphs show means plus SD for triplicate samples and are repre-
sentatives of at least 3 independent experiments. Blots show 1 rep-
resentative of 3 independent experiments.
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extracellular K+ to block efflux were infected and ana-
lyzed as described above. While K+ efflux was essential for 
SLO-mediated inflammasome activation and release of 
mature IL-1β (Fig. 3c), it was dispensable for ubiquitina-
tion of the pro-form (Fig. 3d), which is in line with our 
data suggesting that Nlrp3 inflammasome activation is 
not required for pro-IL-1β ubiquitination.
Pro-IL-1β Ubiquitination after Streptococcal Infection 
Is of Heterogeneous Linkage Specificity
Ubiquitin monomers can be linked together through 
any of their 7 internal lysines or their N-terminal me-
thionine residues, and the nature of this linkage decides 
the fate of the ubiquitinated target [2]. To investigate 
which mode of ubiquitination is present on pro-IL-1β 
after GAS infection, we took advantage of the so-called 
DUBs. The DUBs are a family of enzymes that can spe-
cifically cleave 1 or more type of intra-ubiquitin bonds, 
for example, all linkages or K48 or K63 linkages only [2]. 
Thus, we pulled down pro-IL-1β from BMDMs infected 
with wt GAS and treated the precipitate with different 
DUB enzymes. While the non-specific linkage enzyme 
USP2 as expected detached all ubiquitin moieties on pro-
IL-1β, the K48- and K63-specific DUBs, OTUB1, and 
AMSH, both only partially reduced associated ubiquitin 
signals, suggesting the presence of both types of linkages. 
In contrast, the M1 linkage-specific enzyme Otulin did 
not appear to change the level of ubiquitination, imply-
ing ubiquitin is not attached to pro-IL-1β by M1 linkage 
(Fig. 4a).
The enzyme A20 was first described as an inhibitor of 
the NF-κB activation and has as such a prominent role in 
immune homeostasis [40]. A20 has both E3 ligase and 
deubiquitinase activity and has subsequently been impli-
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Fig. 4. Pro-IL-1β ubiquitination after Group A Streptococcus 
(GAS) infection is of heterogeneous linkage specificity. a lipopoly-
saccharide (LPS)-primed macrophages were infected with wild 
type (wt) GAS followed by precipitation of IL-1β. Precipitates were 
subjected to deubiquitinase (DUB) proteolysis removing ubiquitin 
(Ub) of all linkages (“All”) or specifically K48, K63 or M1 linkages, 
as indicated, and ubiquitin and (pro-)IL-1β were assessed by im-
munoblot. b Immunoblot for A20 in lysates of untreated, primed 
or primed, and infected (wt or Δslo GAS) macrophages, as indi-
cated. c Immunoblot for A20 in IL-1β precipitates from macro-
phages primed and infected with wt or Δslo GAS. d IL-1β was pre-
cipitated from whole cell lysates from macrophages after priming 
and infection with wt or Δslo GAS and analyzed for co-precipita-
tion of the indicated proteins. e B6 and receptor-interacting kinase 
3 (Rip3)–/– macrophages were primed and infected with wt or Δslo 
GAS. Precipitates of IL-1β from cell lysates were assayed for ubiq-
uitin (Ub) and (pro-)IL-1β. Blots show 1 representative of 2 or 3 
independent experiments.
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cated in multiple immune signaling pathways, for exam-
ple, regulating ubiquitination of pro-IL-1β. More specifi-
cally, A20 seems to restrict the ubiquitination of pro-IL-
1β through a mechanism dependent on Rip3, thereby 
limiting secretion of mature IL-1β [9]. Therefore, we in-
vestigated the possibility that GAS infection might reduce 
A20 protein levels, which in turn could allow for increased 
pro-IL-1β ubiquitination. However, LPS-primed, wt- or 
Δslo-infected BMDMs all expressed comparable levels of 
A20, excluding this possibility (Fig.  4b). We further 
found, contrary to previous observations [9], that pro-IL-
1β did not co-precipitate with A20, caspases or Rip ki-
nases (Fig. 4c, d). In addition, our data indicate that pro-
IL-1β ubiquitination was not abolished, but rather in-
creased, by the absence of Rip3 (Fig. 4e). These findings 
agree with the observation that GAS-induced ubiquitina-
tion, contrary to the LPS-mediated, A20-restricted ubiq-
uitination of pro-IL-1β, does not seem to be required for 
the maturation and secretion of this cytokine, and sug-
gests that the infection-driven mechanism governing the 
ubiquitination of pro-IL-1β described here differs from 
mechanisms previously reported.
Pro-IL-1β is Degraded upon Infection with  
SLO-Proficient GAS
Previous studies have proposed that ubiquitinated 
pro-IL-1β protein may be degraded in the proteasome [7, 
10] or by autophagy [41]. Thus, we set out to investigate 
whether GAS infection induces pro-IL-1β degradation, a 
possible outcome downstream of ubiquitination. In order 
to avoid the inflammasome-dependent processing of 
pro-IL-1β, we infected BMDMs lacking the integral in-
flammasome component ASC and observed a decrease in 
pro-IL-1β levels upon infection with wt bacteria as com-
pared to the strain lacking SLO, or uninfected cells, and 
this decrease became more pronounced with time 
(Fig. 5a). In contrast, in macrophages that were infected 
with the SLO prepore-locked mutant slo (Y225A), treated 
with rSLO or infected with ∆slo bacteria in the presence 
of rSLO (all stimuli that induce reduced or no ubiquitina-
tion of pro-IL-1β [Fig. 2a]) degradation was significantly 
reduced (Fig. 5b). As this result supports the hypothesis 
that SLO-dependent pro-IL-1β ubiquitination increases 
protein degradation, we carried out infections in the pres-
ence of well-established inhibitors of the proteasome or 
autophagy, expecting that inhibition of the responsible 
degradative pathway would hamper the reduction of pro-
IL-1β. The proteasome inhibitor MG-132 was not able to 
inhibit, but rather increased, the degradation of pro-IL-
1β (Fig. 5c). However, 3-MA, which blocks autophagy by 
inhibiting phosphatidylinositol 3 kinases, did reduce pro-
IL-1β degradation in wt-infected cells (Fig. 5d), suggest-
ing that the ubiquitination induced by SLO-proficient 
GAS infection may promote increased autophagy-medi-
ated degradation of pro-IL-1β. Because 3-MA is a broad 
inhibitor potentially disturbing multiple cellular process-
es, we performed an additional set of experiments using 
the V-ATPase pump inhibitor Bafilomycin, which pre-
vents the acidification of lysosomes leading to a blockage 
in autophagosome-lysosome fusion and inhibition of au-
tophagic flux. Surprisingly, under the conditions tested, 
Bafilomycin had minimal or no effect on the process 
(Fig. 5e), suggesting either that autophagy may not be re-
sponsible for the breakdown of pro-IL-1β and that 3-MA 
is blocking another degradative process, or that the in-
hibitors are differentially able to inhibit autophagic pro-
cesses under the conditions tested. Neither of the inhibi-
tors induced cell death as determined by LDH release 
(data not shown).
Discussion
During the mid-80s, invasive and life-threatening 
GAS disease increased significantly and it was found that 
these infections were mainly caused by a single clone of 
serotype M1 that was rapidly disseminated worldwide 
[42]. More recently, a similar propagation of an M89 
clone has been observed [43]. Interestingly, both these 
clonal expansions were preceded by the acquisition of a 
genetic region that in these strains conferred increased 
expression of the pore-forming protein SLO and its co-
toxin NADase [43–45], indicating that SLO and NADase 
make important contributions to virulence. In the cur-
rent report, we describe a property of SLO that is likely 
to play an important role in virulence; the ability of SLO 
to drive ubiquitination and degradation of pro-IL-1β in 
infected macrophages, thus limiting the pool of pro-IL-
1β available for inflammasome-mediated maturation 
and release. This previously unknown function for SLO 
may limit the innate immune response evoked by the in-
fection and may at least partly explain why increased 
SLO expression levels correlate with enhanced fitness. It 
is interesting to note that while our data indicate that the 
ubiquitination triggered by SLO limits the release of pro-
cessed IL-1β, SLO also induces secretion of mature IL-1β 
from macrophages [19, 20, 35]. This may reflect the ac-
tivation and simultaneous control of IL-1β release, re-
sulting in optimal circumstances for successful infection 
[22].
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We found that SLO, pure or added to an infection 
with SLO-deficient bacteria, did not increase the level 
of pro-IL-1β ubiquitination, suggesting that SLO has to 
be secreted from the infecting bacterium and that pore-
formation as such is not sufficient, although it is re-
quired, for the ubiquitination of pro-IL-1β. It is inter-
esting to note the resemblance between this observation 
and the ones that have previously been made for SLO-
mediated translocation of NADase, that is, both toxins 
have to be expressed and secreted by the same bacteri-
um for translocation to occur, and translocation cannot 
be rescued in trans by co-infection with 2 bacterial mu-
tants deficient in either toxin [46]. In contrast to the 
pro-IL-1β ubiquitination observed here however, trans-
location is independent of SLO pore formation [38]. 
Clearly, the potential involvement of NADase in pro-
IL-1β ubiquitination is compelling and requires inves-
tigation. However, this problem is complicated by the 
fact that SLO functionality is reduced in the absence of 
NADase and by the finding that the SLO:NADase in-
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Fig. 5. Pro-IL-1β is degraded upon streptolysin O (SLO) profi-
cient Group A Streptococcus (GAS) infection. a Macrophages de-
ficient for the inflammasome linker protein ASC were left un-
treated, primed or primed, and infected with wild type (wt) or 
Δslo Group A Streptococcus (GAS) for the designated time points, 
as indicated, and (pro-)IL-1β levels in whole cell lysates were eval-
uated by immunoblot. b Macrophages deficient for ASC were left 
untreated, primed or primed, and infected with wt, Δslo, or 
slo(Y255A) GAS in the presence or absence of 10 µg/mL recom-
binant SLO (rSLO) for the designated time points, as indicated, 
and pro-IL-1β levels in whole cell lysates were evaluated by im-
munoblot. Lipopolysaccharide (LPS)-primed ASC deficient mac-
rophages were infected with wt GAS for the indicated times in the 
presence of specific inhibitors as follows; c MG-132 (proteasome), 
d 3-MA (autophagy, PI3K inhibitor) or e Bafilomycin (autopha-
gy, V-ATPase inhibitor). Band intensities were quantified based 
on whole protein content of cell lysates loaded onto gels followed 
by normalization to infected cells (without inhibitor) at each time 
point (indicated by arrows). The housekeeping protein GAPDH 
was used as a visual loading control but not as a basis for quanti-
fication. Figure shows representative blots of at least 3 indepen-
dent experiments.
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teraction is partly dependent on a NADase protein do-
main that is removed in translocation mutants [47, 48]. 
In addition, although NADase is currently the only 
known substrate for SLO-mediated translocation, it re-
mains possible that there are other, yet unknown sub-
strates translocated that are involved in the ubiquitina-
tion process.
Our analysis of GAS-infected caspase-1- or ASC-defi-
cient macrophages show that pro-IL-1β ubiquitination 
proceeds independently of these inflammasome compo-
nents, and thus does not require inflammasome forma-
tion and activation. Instead, the knockout BMDMs, in 
particular the ASC-deficient cells, exhibited significantly 
increased levels of ubiquitinated pro-IL-1β. This observa-
tion could be explained by an increase in the amount of 
ubiquitin conjugated to each molecule of pro-IL-1β and/
or an increased ratio of ubiquitinated to non-ubiquitinat-
ed pro-IL-1β in these cells. These options require further 
investigation, and presently we can only speculate that 
our data may propose a role for caspase-1 and especially 
ASC in the regulation of the ubiquitination-degradation 
process. Interestingly, there are several reports describing 
novel roles for the components of the Nlrp3 inflamma-
some, for example, in transcription or regulation of 
phagocytosis and metabolic pathways [49–51], providing 
precedence for non-inflammasome-related functions of 
these proteins.
Ubiquitination of target proteins was initially believed 
to result exclusively in cellular signaling or proteasomal 
degradation as a result of K63 or K48 linkages respective-
ly. However, as the field expanded it became obvious that 
the ubiquitin system is complex and dynamic. For exam-
ple, it has been shown that non-degradative ubiquitin sig-
nals can be modified by the addition of further ubiquitin 
chains leading to the degradation of the target protein 
[52], and it is possible that our observation described here 
relates to this finding. Indeed, we found that LPS induced 
a basal level of ubiquitination of pro-IL-1β, which has 
previously been described to facilitate cytokine matura-
tion and secretion, and that subsequent infection with 
SLO-proficient streptococci significantly increases pro-
IL-1β ubiquitination. The ubiquitin chain(s) linked to 
pro-IL-1β as a result of GAS infection contains a hetero-
geneous mixture of K48 and K63 linkages, and although 
our current analyses do not allow us to draw conclusions 
about relative levels of these 2, or presence of other lysine 
linkage types, our data indicate that the final ubiquitin 
composition is a signature for cytokine degradation rath-
er than maturation and secretion. Indeed, rSLO efficient-
ly activates the inflammasome and generates the release 
of mature IL-1β, but does not induce increased ubiquiti-
nation of the pro-form, suggesting that the GAS-mediat-
ed ubiquitination of the cytokine it not essential for its 
secretion.
We find that infection with GAS expressing SLO leads 
to the degradation of pro-IL-1β, which can be blocked us-
ing the autophagy inhibitor 3-MA. Of note, 3-MA is a 
broad phosphatidylinositol 3 kinases inhibitor known to 
affect multiple cellular processes. As Bafilomycin, which 
is also commonly used to block autophagy, does not pre-
vent the decay of pro-IL-1β, we believe it is still an open 
question whether the degradation truly ensues through 
autophagy or by another yet to be determined pathway. 
Interestingly, the inhibition of the proteasome during in-
fection increased the degradation of pro-IL-1β, which 
may imply that the proteasome normally degrades a yet 
unknown regulating factor of pro-IL-1β stability or turn-
over.
It has previously been reported that several pathogens 
exploit the ubiquitination to interfere with host immune 
responses. For example, human papilloma virus induces 
ubiquitination and proteasome-dependent degradation 
of pro-IL-1β [53], enteropathogenic E. coli downregu-
lates the inflammasome activity by preventing Nlrp3 
deubiquitination [54], and Shigella translocates a bacte-
rial E3 ubiquitin ligase into the host cell and promotes 
the dissemination of the pathogen by inducing cell death 
[55]. Our results identify another mechanism by which 
pathogenic bacteria may exploit ubiquitin pathways of 
the host in order to dampen inflammation. The nature of 
the E3 ligase mediating this ubiquitination event and 
whether it is derived from the host or the bacterium re-
main to be explored. Based on our observations we pro-
pose that GAS-induced pro-IL-1β ubiquitination and 
degradation may represent a previously unrecognized 
immune evasion strategy, designed to directly dampen 
the innate immune response evoked by the invading bac-
terium.
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